Autoimmune Movement Disorders: a Clinical and Laboratory Approach.

about

Autoimmune Movement Disorders: a Clinical and Laboratory Approach.

Item

http://www.wikidata.org/entity/Q39102143

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Autoimmune Movement Disorders: a Clinical and Laboratory Approach.

@en

Autoimmune Movement Disorders: a Clinical and Laboratory Approach.

@nl

type

Item

label

Autoimmune Movement Disorders: a Clinical and Laboratory Approach.

@en

Autoimmune Movement Disorders: a Clinical and Laboratory Approach.

@nl

prefLabel

Autoimmune Movement Disorders: a Clinical and Laboratory Approach.

@en

Autoimmune Movement Disorders: a Clinical and Laboratory Approach.

@nl

P1476

Autoimmune Movement Disorders: a Clinical and Laboratory Approach

@en

P2093

Josephe Archie Honorat

http://www.w3.org/2001/XMLSchema#string

P2860

'Medusa-head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 1: Anti-mGluR1, anti-Homer-3, anti-Sj/ITPR1 and anti-CARP VIII

Myoclonic encephalopathy of infants

Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis

Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis

Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study

Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies

Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma

'Medusa head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 3: Anti-Yo/CDR2, anti-Nb/AP3B2, PCA-2, anti-Tr/DNER, other antibodies, diagnostic pitfalls, summary and outlook

'Medusa head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 2: Anti-PKC-gamma, anti-GluR-delta2, anti-Ca/ARHGAP26 and anti-VGCC

DPPX potassium channel antibody: frequency, clinical accompaniments, and outcomes in 20 patients.

P2888

s11910-017-0709-2

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11910-017-0709-2

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Andrew McKeon

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28120141

http://www.w3.org/2001/XMLSchema#string